Evolva(瑞士)

Evolva SA

瑞士EvolvaSA www.evolva.com瑞士生物科技公司Evolva是一家研發(fā)治療動(dòng)脈血栓形成以及真菌感染的公司。而諾華投資（NovartisVenture）阿拉維（Aravis），太陽(yáng)石資本（SunstoneCapita）以及丹麥創(chuàng)新資本集團(tuán)（DanskInnovations）都是其投資者之一。Evolvawasfoundedin2004aroundadistinctive,propr ietary,technologyplatformthatusessyntheticbiologytocreateinnovativesmallmoleculedrugsandothercompounds.Inparticularourplatformallowsthecreationofchemistriesthatrecapitulatethethemesfoundinnaturalproducts,butwithoutthedisadvantagesofthoseapproaches.Wehaveusedthisplatformacrossarangeofpharmaceuticalandrelatedapplicationsandhavecreatedapipelineofstronglydifferentiatedcompoundsthataddressmajorunmetmedicalneeds.Ourcompoundsareorallyavailable,potentandcovernewstructuralclassesand/ornewmechanisms.Ourthreemostimportantcompoundsare:EV-077forrenaldiseaseandarterialthrombosis.EV-077isinPhaseIEV-086forfungalinfections.EV-086is